IFITM1 and COVID-19: Similarly, other genes involved in type I interferon signaling (IFITM1 and IFITM3) and cellular activation (UBC, FOS, and DUSP1) were increased in a severity-dependent manner (Figure 5B), suggesting an enhanced EF B-cell activity associated with an overt inflammatory condition in severe COVID-19.